Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Case and Commentary Dec 2022 How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters? Adam T. Perzynski, PhD and Kurt C. Stange, MD, PhD Patients experiencing homelessness and mental illness face conditions and circumstances that deserve focused ethical and clinical attention. AMA J Ethics. 2022;24(12):E1112-1120. doi: 10.1001/amajethics.2022.1112. State of the Art and Science Jun 2005 Recognition and Treatment of Depression Holly A. Swartz, MD Virtual Mentor. 2005;7(6):430-434. doi: 10.1001/virtualmentor.2005.7.6.cprl1-0506. State of the Art and Science Jun 2007 Attention Deficit Hyperactivity Disorder in Childhood: Overview, Diagnosis and Treatment Sarah Maitre Virtual Mentor. 2007;9(6):433-436. doi: 10.1001/virtualmentor.2006.8.10.ccas4-0610. State of the Art and Science Oct 2006 Diagnosis and Treatment of Conduct Disorder Suma Jacob, MD, PhD Virtual Mentor. 2006;8(10):672-675. doi: 10.1001/virtualmentor.2006.8.10.cprl1-0610. State of the Art and Science Jul 2008 Managing Somatization Disorder Robert McCarron, DO Virtual Mentor. 2008;10(7):447-452. doi: 10.1001/virtualmentor.2008.10.7.cprl1-0807. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. State of the Art and Science Nov 2016 What’s in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care Madeline B. Deutsch, MD, MPH, Asa Radix, MD, MPH, and Sari Reisner, ScD Research should be conducted on transgender populations to inform evidence-based guidelines for gender-affirming treatment. AMA J Ethics. 2016;18(11):1098-1106. doi: 10.1001/journalofethics.2016.18.11.stas1-1611. Pagination Current page 1 Page 2 Next page Next › Last page Last »
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Case and Commentary Dec 2022 How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters? Adam T. Perzynski, PhD and Kurt C. Stange, MD, PhD Patients experiencing homelessness and mental illness face conditions and circumstances that deserve focused ethical and clinical attention. AMA J Ethics. 2022;24(12):E1112-1120. doi: 10.1001/amajethics.2022.1112.
State of the Art and Science Jun 2005 Recognition and Treatment of Depression Holly A. Swartz, MD Virtual Mentor. 2005;7(6):430-434. doi: 10.1001/virtualmentor.2005.7.6.cprl1-0506.
State of the Art and Science Jun 2007 Attention Deficit Hyperactivity Disorder in Childhood: Overview, Diagnosis and Treatment Sarah Maitre Virtual Mentor. 2007;9(6):433-436. doi: 10.1001/virtualmentor.2006.8.10.ccas4-0610.
State of the Art and Science Oct 2006 Diagnosis and Treatment of Conduct Disorder Suma Jacob, MD, PhD Virtual Mentor. 2006;8(10):672-675. doi: 10.1001/virtualmentor.2006.8.10.cprl1-0610.
State of the Art and Science Jul 2008 Managing Somatization Disorder Robert McCarron, DO Virtual Mentor. 2008;10(7):447-452. doi: 10.1001/virtualmentor.2008.10.7.cprl1-0807.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
State of the Art and Science Nov 2016 What’s in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care Madeline B. Deutsch, MD, MPH, Asa Radix, MD, MPH, and Sari Reisner, ScD Research should be conducted on transgender populations to inform evidence-based guidelines for gender-affirming treatment. AMA J Ethics. 2016;18(11):1098-1106. doi: 10.1001/journalofethics.2016.18.11.stas1-1611.